Holen Sie sich die Stockscreener-App
625.24
0.38%
-2.545
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$627.78
Offen:
$639.11
24-Stunden-Volumen:
128.24K
Relative Volume:
0.24
Marktkapitalisierung:
$50.03B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$985.66M
KGV:
52.04
EPS:
12.0143
Netto-Cashflow:
$774.34M
1W Leistung:
-2.12%
1M Leistung:
-2.74%
6M Leistung:
+65.01%
1J Leistung:
+32.38%
1-Tages-Spanne:
$622.15
$639.11
1-Wochen-Bereich:
$600.57
$642.25
52-Wochen-Spanne:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
625.37 | 50.23B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
540.16 | 205.40B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.03 | 151.60B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
A
Agilent Technologies Inc
|
139.33 | 40.15B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
202.39 | 34.85B | 15.70B | 1.24B | 2.01B | 6.9036 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories Elects Karen Peacock as Director, Effective October 6, 2025 - MarketScreener
Karen Peacock joins IDEXX Laboratories board of directors By Investing.com - Investing.com Australia
IDEXX Laboratories Appoints Karen Peacock to Board - TipRanks
IDEXX Laboratories Elects Karen Peacock to Board of Directors - Business Wire
What analyst consensus implies for IDEXX Laboratories Inc. (IX1) stockMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Can you recover from losses in IDEXX Laboratories Inc.July 2025 Summary & Real-Time Stock Price Movement Reports - newser.com
Can trapped investors hope for a rebound in IDEXX Laboratories Inc.July 2025 Retail & Free Reliable Trade Execution Plans - newser.com
IDEXX Laboratories Inc. stock volume spike explained2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Will IDEXX Laboratories Inc. stock split again soon2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
IDEXX Laboratories Hits Day High with Strong 3.35% Intraday Surge - Markets Mojo
IDEXX Laboratories Stock Price, Quotes and Forecasts | NASDAQ:IDXX - Benzinga
Published on: 2025-10-03 20:35:20 - earlytimes.in
IDEXX Laboratories, Inc. (IDXX) Stock Delivers 97% Return in 3 Years, Outpacing Zoetis and Market - MSN
IDEXX Laboratories: Recurring Revenue And Market MoatWhy I Choose To Buy - Seeking Alpha
UBS Initiates Coverage of IDEXX Laboratories (IDXX) with Neutral Recommendation - Nasdaq
IDEXX Laboratories Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Technical analysis overview for IDEXX Laboratories Inc. stock2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
UBS Initiates IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Announces Target Price $720 - 富途牛牛
Chicago Capital LLC Reduces Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by State of Alaska Department of Revenue - MarketBeat
IDEXX Laboratories launch new Urine P:C Ratio for VetTest - DVM360
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive? - Zacks Investment Research
496 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Symmetry Partners LLC - MarketBeat
What analysts say about IDEXX Laboratories Inc IX1 stockMarket Volatility Update & Small Capital Trading Growth - Early Times
ORG Wealth Partners LLC Makes New $273,000 Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Patton Fund Management Inc. Makes New $269,000 Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Dakota Wealth Management Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Rating Lowered to Buy at Wall Street Zen - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Holdings Increased by Public Employees Retirement System of Ohio - MarketBeat
Old Port Advisors Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
What drives IDEXX Laboratories Inc stock pricePrice Momentum Alerts & High Profit Portfolio Growth - Early Times
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Mather Group LLC. - MarketBeat
Novem Group Lowers Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Hits Day Low of $621.36 Amid Price Pressure - Markets Mojo
What Does the Market Think About IDEXX Laboratories? - Benzinga
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$627 Based On Its Intrinsic Value? - Yahoo Finance
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Grows Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
501 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Castleview Partners LLC - MarketBeat
Riverbridge Partners LLC Lowers Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
400 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Genesis Wealth Advisors LLC - MarketBeat
Retireful LLC Invests $288,000 in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Purchased by Waycross Partners LLC - MarketBeat
Swedbank AB Purchases 2,324 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories' (NASDAQ:IDXX) investors will be pleased with their decent 97% return over the last three years - Berawang News
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.69%
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):